Neural tube defects: Prevalence, etiology and prevention

被引:90
|
作者
Kondo, Atsuo [1 ]
Kamihira, Osamu [2 ]
Ozawa, Hideo [3 ]
机构
[1] Tsushima Rehabil Hosp, Dept Urol, Tsushima, Aichi 4960072, Japan
[2] Komaki Shimin Hosp, Dept Urol, Aichi, Japan
[3] Okayama Rosai Hosp, Dept Urol, Okayama, Japan
关键词
folic acid; gene polymorphism; homocysteine; neural tube defects; supplementations; FOLIC-ACID FORTIFICATION; MATERNAL CIGARETTE-SMOKING; UNITED-STATES; SPINA-BIFIDA; CHILDBEARING AGE; PLASMA FOLATE; PREGNANCY; WOMEN; RISK; ANTAGONISTS;
D O I
10.1111/j.1442-2042.2008.02163.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Spina bifida and anencephaly, the common form of neural tube defects, affect approximately 300 000 newborns each year worldwide. The effectiveness of folic acid supplementation in preventing their occurrence or recurrence has been unambiguous since 1991. In general, the prevalence of these abnormalities has decreased in the past 20 to 30 years because of periconceptional folate supplementation, food fortification in several countries, avoiding exposure to environmental factors, and increased accuracy of prenatal screening for fetal anomalies. Women who are planning to conceive should be informed about the importance of folic acid in fetal development and advised to take 400 mu g/day of folic acid supplements. Food fortification with folic acid will ultimately be necessary to reduce the number of patients. Primary prevention of neural tube defects by the periconceptional intake of folic acid is a major public health opportunity and has wide implications in reducing the mortality and morbidity of offspring.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 50 条
  • [41] Folic acid for the prevention of neural tube defects
    da Fonseca, Eduardo Borges
    Raskin, Salmo
    Zugaib, Marcelo
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2013, 35 (07): : 287 - 289
  • [42] Folic acid for prevention of neural tube defects
    Tonz, O
    Luthy, J
    Raunhardt, O
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 (05) : 177 - 187
  • [43] PRESENT STATUS OF PREVENTION OF NEURAL TUBE DEFECTS
    NADLER, HL
    PEDIATRICS, 1975, 55 (06) : 751 - 753
  • [44] Prevention of neural tube defects by inositol (PONTI)
    Chitty, Lyn
    Greene, N. D. E.
    Burren, K.
    Hesketh, T.
    Copp, A.
    JOURNAL OF MEDICAL GENETICS, 2006, 43 : S45 - S45
  • [45] Folic acid and prevention of neural tube defects
    Ryan-Harshman, Milly
    Aldoori, Walid
    CANADIAN FAMILY PHYSICIAN, 2008, 54 (01) : 36 - 38
  • [46] Trend in prevalence of neural tube defects in Quebec
    De Wals, P
    Rusen, ID
    Lee, NS
    Morin, P
    Niyonsenga, T
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2003, 67 (11) : 919 - 923
  • [47] PREVENTION OF RECURRENCE OF NEURAL-TUBE DEFECTS
    MONTELEONENETO, R
    FROTAPESSOA, O
    REVISTA BRASILEIRA DE GENETICA, 1985, 8 (03): : 621 - 624
  • [48] Are the recommendations on the prevention of neural tube defects working?
    Stoll, C.
    Alembik, Y.
    Dott, B.
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2006, 49 (06) : 461 - 465
  • [49] Folic acid for the prevention of neural tube defects
    Desposito, F
    Desposito, F
    Cunniff, C
    Frias, JL
    Panny, SR
    Trotter, TL
    Wappner, RS
    Hanson, JW
    Elias, S
    Moore, CA
    Lloyd-Puryear, M
    de la Cruz, F
    Pletcher, BA
    Cho, SC
    PEDIATRICS, 1999, 104 (02) : 325 - 327
  • [50] The emerging role of epigenetic mechanisms in the etiology of neural tube defects
    Greene, Nicholas D. E.
    Stanier, Philip
    Moore, Gudrun E.
    EPIGENETICS, 2011, 6 (07) : 875 - 883